New York S 9523: Relates to coverage for treatments to slow the progression of Alzheimer's disease and related dementias

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S09523 Summary:

BILL NOS09523 

&nbsp

SAME ASSAME AS A10748

&nbsp

SPONSORCLEARE

&nbsp

COSPNSRADDABBO, GONZALEZ, HARCKHAM, PARKER, SKOUFIS

&nbsp

MLTSPNSR

&nbsp

Amd §§3216, 3221 & 4303, Ins L; amd §365-a, Soc Serv L

&nbsp

Provides for coverage for treatments to slow the progression of Alzheimer's disease and related dementias.

Go to top S09523 Actions:

BILL NOS09523 

&nbsp

03/19/2026REFERRED TO INSURANCE

Go to topS09523 Committee&nbspVotes:

Go to topS09523 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS09523 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 9523

 IN SENATE

 March 19, 2026
 ___________

 Introduced by Sen. CLEARE -- read twice and ordered printed, and when
 printed to be committed to the Committee on Insurance

 AN ACT to amend the insurance law and the social services law, in
 relation to coverage for treatments to slow the progression of
 Alzheimer's disease and related dementias

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subsection (i) of section 3216 of the insurance law is
 2 amended by adding a new paragraph 11-d to read as follows:
 3 (11-d) Every policy which provides medical, major medical, or similar
 4 comprehensive-type coverage shall provide coverage for all medically
 5 necessary diagnostic testing and United States food and drug administra-
 6 tion-approved treatments or medications prescribed to slow the progres-
 7 sion of Alzheimer's disease and other dementia, in accordance with the
 8 United States food and drug administration label, as determined by a
 9 physician licensed to practice medicine in all its branches. Coverage of
 10 United States food and drug administration-approved treatments or medi-
 11 cations prescribed to slow the progression of Alzheimer's disease or
 12 another related dementia pursuant to this paragraph shall not be subject
 13 to step therapy.
 14 § 2. Subsection (l) of section 3221 of the insurance law is amended by
 15 adding a new paragraph 11-d to read as follows:
 16 (11-d) Every insurer delivering a group or blanket policy or issuing a
 17 group or blanket policy for delivery in this state that provides cover-
 18 age for medical, major medical, or similar comprehensive-type coverage
 19 shall provide coverage for all medically necessary diagnostic testing
 20 and United States food and drug administration-approved treatments or
 21 medications prescribed to slow the progression of Alzheimer's disease
 22 and other dementia, in accordance with the United States food and drug
 23 administration label, as determined by a physician licensed to practice
 24 medicine in all its branches. Coverage of United States food and drug
 25 administration-approved treatments or medications prescribed to slow the
 26 progression of Alzheimer's disease or another related dementia pursuant
 27 to this paragraph shall not be subject to step therapy.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD15298-01-6

 S. 9523 2

 1 § 3. Section 4303 of the insurance law is amended by adding a new
 2 subsection (p-2) to read as follows:
 3 (p-2) A medical expense indemnity corporation, a hospital service
 4 corporation or a health service corporation that provides coverage for
 5 medical, major medical, or similar comprehensive-type coverage shall
 6 provide coverage for all medically necessary diagnostic testing and
 7 United States food and drug administration-approved treatments or medi-
 8 cations prescribed to slow the progression of Alzheimer's disease and
 9 other dementia, in accordance with the United States food and drug
 10 administration label, as determined by a physician licensed to practice
 11 medicine in all its branches. Coverage of United States food and drug
 12 administration-approved treatments or medications prescribed to slow the
 13 progression of Alzheimer's disease or another related dementia pursuant
 14 to this subsection shall not be subject to step therapy.
 15 § 4. Subdivision 2 of section 365-a of the social services law is
 16 amended by adding a new paragraph (mm-1) to read as follows:
 17 (mm-1) all medically necessary diagnostic t